TCL Archive Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time April 16, 1999
TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013